• John Stack was hired as senior managing director, aerospace and defense investment banking for B. Riley Securities Inc., an investment bank and subsidiary of B. Riley Financial. Stack joins B. Riley from Canaccord Genuity. Prior to his investment banking career, he held executive roles with Cessna Aircraft Co. and Textron. 
• Scott Hadfield was named senior managing director and national practice leader for capital advisory by Hilco Corporate Finance, Hilco Global‘s investment banking advisory firm. Hadfield was previously managing director, corporate finance for Alantra. 
• Hudson Collins was appointed director by William Blair, a global boutique with experience in investment banking, investment management and private wealth management. He comes from Credit Suisse, where he served as a director in private funds group, and has held roles with Eaton Partners, MVision Private Equity Advisers and McColl Partners. 
• Suraj Tolani was hired by JPMorgan Chase & Co. as a managing director on its regional investment banking team focusing on middle-market, U.S. healthcare services companies. Tolani joins from boutique investment bank Moelis & Co. and will report to John Richert, head of regional investment banking. 
• Kaitlin Fronczek was named director of investor relations by Ara Partners, a private equity firm focused on industrial decarbonization investments. Fronczek joins from Apax Partners where she served as VP. She also served in investor relations at Tailwind Capital and Lionhart. 
• Banco Santander, MUFG, National Australia Bank, Natixis Corporate & Investment Banking and SMBC provided a $515 million renewable energy green loan to Eolian, a Global Infrastructure Partners portfolio company, which operates energy storage projects and develops and invests in renewable energy and clean molecule projects. 
• Fidelity Management & Research Company and Catalyst Health Ventures participated in a $35 million Series D funding round for Conformal Medical, a medical device company developing devices to prevent stroke in patients with non-valvular Afib. 
• Apollo agreed to invest $2 billion in preferred equity securities to be issued by AT&T Mobility II. The AT&T subsidiary will use the funds in part to replace $8 billion of preferred interests that were outstanding prior to the fourth quarter of 2022. 
• General Catalyst led a $100 million Series B financing round for Charm Industrial, a carbon removal tech company. Lowercarbon Capital, Exor Ventures, Kinnevik, Thrive Capital and Elad Gil participated in the funding. General Catalyst’s CEO and Managing Director Hemant Taneja will join Charm’s board alongside Ryan Panchadsaram. 
• Pfizer Ventures, AbbVie Ventures, Ono Venture Investment and UPMC Enterprises participated in a $25 million Series A extension for Mozart Therapeutics, a developer of treatments for autoimmune and inflammatory diseases. The round brought the total amount to $80 million. Marie-Claire Peakman, PhD, Partner of Pfizer Ventures, and Jasmina Marjanovic, PhD, Director AbbVie Ventures, will join Mozart’s Board. 

Hear from industry leaders in alternative assets like Capital Innovations Founder, CEO and CIO, and ADISA President Michael Underhill. Connect in person with top executives in private credit, real estate and more at the Connect Money: Alternative Assets Conference in Chicago on June 14 at the W City Center.